GS0421: Providing information in the field of scientific and medical research; laboratory research in the field of enzyme inhibitors, scientific research, product research and development, pharmaceutical drug development, design and testing for new product development, development of new technology with others and product development collaborations in the nature of consultation services, both in the field of medical drug development and enzyme usage ultimately leading to regulatory submission, approval and commercialization
Case File Event Statements
5/17/2012 - 13 years ago
18 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILEDType:NA85
5/17/2012 - 13 years ago
17 - REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.Type:C15A
5/17/2012 - 13 years ago
16 - CASE ASSIGNED TO POST REGISTRATION PARALEGALType:APRE
5/8/2012 - 13 years ago
15 - TEAS SECTION 8 & 15 RECEIVEDType:E815
8/4/2010 - 15 years ago
14 - ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLYType:ASCK
11/8/2005 - 20 years ago
13 - REGISTERED-PRINCIPAL REGISTERType:R.PR
8/16/2005 - 20 years ago
12 - PUBLISHED FOR OPPOSITIONType:PUBO
7/27/2005 - 20 years ago
11 - NOTICE OF PUBLICATIONType:NPUB
4/25/2005 - 20 years ago
10 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
4/22/2005 - 20 years ago
9 - ASSIGNED TO LIEType:ALIE
4/15/2005 - 20 years ago
8 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
4/14/2005 - 20 years ago
7 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
4/5/2005 - 20 years ago
6 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
4/5/2005 - 20 years ago
5 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA